Connecting Specialized Medical Knowledge<\/h2>\n
![\"GMP-WHO](\"https:\/\/vinphaco.net\/wp-content\/uploads\/2026\/04\/2-640x427.jpg\")
<\/p>\n
Organized by the Vietnam Association of Critical Care Medicine, Emergency and Clinical Toxicology,<\/a> the congress acts as a convergence point for leading experts in emergency and intensive care.<\/p>\n The 2026 program focused on key strategic areas:<\/p>\n Updating the latest medical knowledge and clinical advances in critical care, emergency, and clinical toxicology.<\/p>\n<\/li>\n Sharing practical, evidence-based experiences in treating severe clinical cases.<\/p>\n<\/li>\n Enhancing the professional capacity and treatment efficacy for healthcare professionals.<\/p>\n<\/li>\n<\/ul>\n Beyond an academic exchange, the congress plays a pivotal role in the ongoing medical training and sustainable development of the intensive care sector.<\/p>\n As a leading GMP-WHO pharmaceutical manufacturer<\/b><\/a>, Vinphaco continuously reaffirms its long-term commitment to the healthcare industry and medical professionals. During the event, Vinphaco sponsored and accompanied nearly 50 leading delegates and intensive care physicians. This active participation reflects our core development strategy: aligning advanced pharmaceutical manufacturing with real-world clinical practices to achieve the ultimate goal of community health.<\/p>\n At the exhibition area, the Vinphaco booth attracted significant attention from healthcare professionals. It served as an interactive space for medical experts to exchange knowledge and discover our high-quality treatment solutions tailored for intensive care units. This activity not only fostered direct engagement between our enterprise and medical practitioners but also highlighted the practical application of our products in critical life-saving treatments.<\/p>\n For international distributors looking for high-quality intensive care medications, choosing the right partner is crucial. Operating as a strictly regulated GMP-WHO pharmaceutical manufacturer<\/b>, Vinphaco specializes in manufacturing premium injectables. We utilize the most advanced Blow-Fill-Seal (BFS) technology and lyophilization (freeze-drying)<\/a> processes.<\/p>\n These cutting-edge manufacturing lines ensure the absolute sterility and stability of critical care products, which are vital for emergency rooms worldwide. Our extensive product portfolio includes high-quality antibiotic injections, Vitamin B complex injections, corticosteroid treatments, and nebulizer pharmaceutical solutions.<\/p>\n Furthermore, our robust Regulatory Affairs team ensures that all our products come with comprehensive Common Technical Document (CTD) dossiers. This readiness significantly accelerates the registration process for our B2B partners across ASEAN, the Middle East, Africa, and South America, empowering distributors to enter new markets with absolute confidence.<\/p>\n\n
Vinphaco\u2019s Commitment to the Intensive Care Sector<\/h2>\n
![\"GMP-WHO](\"https:\/\/vinphaco.net\/wp-content\/uploads\/2026\/04\/0-1-640x427.jpg\")
<\/p>\nThe Vinphaco Exhibition Booth: A Hub for Professional Connection<\/h2>\n
![\"\"](\"https:\/\/vinphaco.net\/wp-content\/uploads\/2026\/04\/3-640x427.jpg\")
<\/p>\n![\"\"](\"https:\/\/vinphaco.net\/wp-content\/uploads\/2026\/04\/4-640x427.jpg\")
<\/p>\nAdvanced Capabilities of a Top GMP-WHO Pharmaceutical Manufacturer<\/h2>\n
![\"\"](\"https:\/\/vinphaco.net\/wp-content\/uploads\/2026\/04\/1-640x427.jpg\")
<\/p>\nSteadfastly Accompanying Global Public Health<\/h2>\n